
Regulatory delays in a multinational clinical stroke trial
Author(s) -
Jeroen C. de Jonge,
Hendrik Reinink,
Bridget Colam,
Iris Alpers,
Alfonso Ciccone,
László Csiba,
Janika Kõrv,
Iwona KurkowskaJastrzębska,
Malcolm Macleod,
George Ntaios,
Götz Thomalla,
Philip M. Bath,
H. Bart van der Worp
Publication year - 2021
Publication title -
european stroke journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 16
eISSN - 2396-9881
pISSN - 2396-9873
DOI - 10.1177/23969873211004845
Subject(s) - clinical trial , medicine , stroke (engine) , regulatory authority , randomized controlled trial , physical therapy , surgery , political science , mechanical engineering , public administration , engineering
The initiation and conduct of randomised clinical trials are complicated by multiple barriers, including delays in obtaining regulatory approvals. Quantitative data on the extent of the delays due to national or local review in randomised clinical trials is scarce.